Pulsus is hosting edition Euro Cardiology Congress 2020 as “International Conference on Cardiology and Cardiology Research on November 04-05, 2020 at Prague, Czech Republic.”
The theme focused for the Cardiology meet is “Perceptions of Cardiac Health and Research on Cardiology”
Having you all with us for our Euro Cardiology Congress 2020 is a matter of great joy and excitement. We look forward to you all sharing your incredible knowledge, research ideas and to make a sprinkle with new enhancements at this 2-days event.
This time we have introduced some new highlights for our Euro Cardiology Congress 2020
Heart failure and cardiomyopathy, clinical cardiology, molecular cardiology, nuclear cardiology, cardio-oncology, cardio-vascular medicine, thoracic and cardiac surgery, congenital cardiac disease and pediatric cardiology, arrhythmias and clinical electrophysiology, cardiovascular diabetology, obesity and stroke, Cardiac nursing and Healthcare, Cardiovascular Research, Cardiac Anesthesiology, Non-Invasive Imaging, Heart Devices, Cardiovascular risk factor, Hypertension, Prevention/rehabilitation, Case reports in Cardiology.
Euro Cardiology Congress 2020 aims to bring all the Science professionals under all fields for our Cardiology Meeting to interact and share their knowledge and their newest research to the entire Cardiology Community
Also, this time, Our Prague Euro Cardiology Congress 2020 Conference will be focus destination for the International Cardiology Research Societies, Associations, and Organizations. This event will bring together Cardiologists, practitioners, Directors, Professors, Students from academia and researchers in the field of Cardiology and Cardiology Research, Government officials and global leaders to push forward the Wound Care 2020
Euro Cardiology Congress 2020 event is expecting more than 200+ Participants to enlighten the program. This time the Euro Cardiology Congress Conference will organize several Oral and Poster Presentations/Networking Sessions/Workshops/Symposiums/Exhibition as we have introduced several new tracks to bring in more participants.
The demand for heart disease, which involves a range of diseases such as hypertension, coronary artery disorders, cardiac arrest, dyslipidaemia, and thrombotic events, is expected to rise from $129.2 billion in 2015 to $146.4 billion by 2022, at a very modest compound annual growth rate of 1.8%, according to business intelligence provider GBI Research.
‘Novartis’ heart-failure drug Entresto was introduced to the market in July 2015, and GBI Research expects its revenues to increase dramatically during the forecast period. Entresto is a combination drug that has demonstrated effectiveness in clinical trials. Coupled with a high cost, which amounts to over $4 500 annually per patient, the drug contributes to a very high revenue forecast of $5.7 billion by 2022.
The sheer number of expirations and approvals means a significant shift in the market structure. According to the International Society for Heart and Lung Transplantation Registry, every year approximately 500-600 pediatric heart transplantation procedures are performed globally, representing approximately 12% of the total number of heart transplants performed in all patients. And in 2014, a total number of globally executing pediatric heart transplants was 586. For infants, because of congenital heart defect and cardiomyopathy, the most commonly triggered heart failure occurs. The increased rate of cardiac insufficiency has thus increased the death rate in children. Thus, in children with this disorder, this increasing rate of heart failure has increased the fatality rate.
The global market for a heart transplant is expected to grow at a CAGR (Compound Annual Growth Rate) of 11.2% during the forecast period of 2017-2023. In the forecast period, the global market for Interventional Cardiology is expected to grow at a steady rate and will post a CAGR of more than 7 percent. Increasing demand for minimally invasive (MI) procedures in the coming years will drive growth prospects for the global market for Interventional Cardiology.
Different countries achieved a high-profit margin due to cardiological disorders and continued their work with new innovations and findings to improve and better cure all kinds of heart disorders.
Cardiology is a division in the medical field that is continuously evolving. People in this era both young and old are vulnerable to heart disorders which are mainly due to their lifestyle and improper hygiene Cardiology study has gained great importance in overtime to tackle these diseases and their causes. Interventional cardiology is a part of cardiology that uses minimally invasive methods to correct disorders using a catheter that helps doctors and patients with less blood loss and minimal risk.
Benefits of attending:
All 2 days programs
Grow Your Professional Network
Build Your Knowledge Base
Expand Your Resource
Meet Experts & Influence Face to Face
A free abstract of paper in our Paper
Learning in a New Room
Accepted Abstracts will be published in the respective supporting journals, each abstract will be labeled with a DOI from Cross Ref,
Certificate of Presentation from the International Organizing Committee,
Break Out of Your Comfort
Best Poster Awards.
Best Start-Up Awards.
New Tips & Tactics
The Serendipity of the Random Workshop